Your session is about to expire
← Back to Search
11C-ER176 for Alzheimer's Disease
Phase 1 & 2
Waitlist Available
Led By Patrick Lao, PhD
Research Sponsored by William Charles Kreisl
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Written and oral fluency in English
Age 50 and older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to one year from baseline
Awards & highlights
Study Summary
This study is evaluating whether a radioactive chemical can be used to measure inflammation in the brain of individuals with Alzheimer's disease.
Eligible Conditions
- Alzheimer's Disease
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to one year from baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to one year from baseline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
11C-ER176 Total Distribution Volume
Secondary outcome measures
11C-ER176 Standardized Uptake Value Ratio
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Cognitive impairmentExperimental Treatment2 Interventions
Alzheimer's disease (mild cognitive impairment or mild stage Alzheimer's disease dementia)
Group II: No cognitive impairmentActive Control2 Interventions
Healthy Controls
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
11C-ER176
2018
Completed Phase 2
~10
Florbetaben (18F)
FDA approved
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
William Charles KreislLead Sponsor
6 Previous Clinical Trials
547 Total Patients Enrolled
Columbia UniversityLead Sponsor
1,431 Previous Clinical Trials
2,460,822 Total Patients Enrolled
Patrick Lao, PhDPrincipal InvestigatorColumbia University
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger